In the News
Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform
Propeller Health, a digital health company dedicated to the management of asthma and COPD, announced that it has received 501(k) clearance from the FDA to connect patients using AstraZeneca’s Symbicort Inhaler to its digital health platform. The Propeller Health platform already connects to the majority of inhalers...
Drone deliveries are making their case in a crisis
With the coronavirus pandemic forcing people to spend most of their time indoors and, when possible, maintain social distancing, and with companies instituting numerous measures to minimize the threat and spread of infection, there has to be a safer and quicker method of exchanging goods and services. The good news...
Amwell Raises $194 Million, Committing to Expand the Best and Largest Digital Health Platform
Amwell has announced that it has closed its Series C financing round, adding $194 million in funding across two tranches. Many early investors and strategic partners participated in this round, including Allianz X and Takeda. Amwell will use significant parts of the funds to expand its investment in technology and...
Digital Health Investments See Significant Uptick in Q1; Investors Consider COVID-19 Impacts in Coming Months
COVID-19 has brought changes and uncertainty to the entire venture-backed ecosystem. Nonetheless, the digital health sector saw its best first quarter since analysts started tracking its performance more than 10 years ago: according to Rock Health data, the sector logged $3.1 billion in investment across 107 deals....
Study finds slight rebound in patient volumes in May, but physicians still in danger financially
A study published recently by the Commonwealth Fund shows that although visits to ambulatory care practices have rebounded slightly, physicians are still facing major obstacles to get their practices back to pre-pandemic levels. The Commonwealth Fund data released April 23 shows that the number of visits to...
Aetion Launches Research Collaboration with FDA to Advance Understanding of COVID-19
Aetion has signed a research collaboration agreement with the U.S. Food and Drug Administration to use real-world data to advance the understanding of and response to coronavirus disease (COVID-19). The research will support the FDA’s objectives to explore the natural history of the disease, as well as treatment and...
Hims & Hers, Vault Health now sell FDA-authorized home COVID-19 tests via telehealth
Less than a week ago, the FDA authorized a home-collected saliva test for COVID-19. Now that test is available through telehealth companies Hims & Hers and Vault Health. Hims & Hers has greatly expanded its telehealth offerings over the past few months to meet the demand for telehealth primary care services....
U.S. Sees Dramatic Drop in Routine Testing Amid Pandemic
A new report from Komodo Health shows that diagnostic testing for cancer and other conditions has declined across the U.S. since mid-March following regional lockdowns for the COVID-19 pandemic. Komodo Health analyzed billing records of 320 million patients from March 19 through April 20 and found that cervical...
GRAIL to Participate in BofA Securities 2020 Health Care Conference
GRAIL has announced that two of its executives will be speaking at the BofA Securities 2020 Health Care Conference. Hans Bishop, Chief Executive Officer; and Joshua Ofman, MD, MSHS, Chief Medical Officer and External Affairs, will provide an overview of the company at the virtual conference, which will take place...
Vivante Health Joins Accolade Trusted Supplier Program
Vivante Health, a provider of digital medicine tools for digestive health and disease, has joined the Accolade Partner Ecosystem as part of the company’s Trusted Supplier Program. GIThrive is Vivante’s digital gut health platform. Using proprietary algorithms and data from each user’s symptom and food log, GIThrive...
Press Releases
Cleveland Clinic Joins Interventional Study Using GRAIL’s Multi-Cancer Early Detection Test to Help Guide Clinical Care
Cancer detection company GRAIL has announced that Cleveland Clinic has joined GRAIL’s PATHFINDER Study, a prospective, multi-cancer clinical study that is evaluating the implementation of Galleri™, an investigational multi-cancer early detection blood test, into...
Komodo Health Lauded by Frost & Sullivan for Empowering Healthcare Stakeholders with Dynamic Real-world Evidence Solutions
Based on its recent analysis of the North American real-world evidence (RWE) solutions market in healthcare, Frost & Sullivan has recognized Komodo Health with the 2020 North American Company of the Year award. Komodo Health’s comprehensive real-time Healthcare...
Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe
Aetion and Cegedim Health Data announced a new partnership to integrate Cegedim’s European real-world data (RWD) platform, THIN, into the Aetion Evidence Platform. The new collaboration will enable Aetion’s clients, including top biopharma companies, leading payers,...
Evidation Raises $45 Million Series D, Hires CCO To Accelerate Commercial Momentum and Expand Into Virtual Health
Evidation Health has announced the close of a $45 million Series D funding round to power the expansion of its privacy-first, direct-to-person research platform, Achievement, to include virtual health. The company will use the new capital to build upon its existing...
New Survey Reveals Patients Have Been Overwhelmingly Satisfied with Virtual Care During the COVID-19 Pandemic and Want Greater Access to it in the Future
Kyruus recently surveyed 1,000 patients about their virtual care experiences during the COVID-19 pandemic. The findings reveal that nearly three-quarters of the respondents engaged in their first telemedicine experience ever during the initial surge of COVID-19 cases...